IRHOU (IRHOU) Stock Price & Analysis
IRHOU (IRHOU) closed at USD 10.14 on Thursday, October 15, 2026, down 0.29% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 10.17; the Oct 15, 2026 session ranged USD 10.14–10.14 on volume of 100 shares. Market capitalization is —, with a 52-week range of USD 9.94–11.29 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IRHOU.md
Key facts (IRHOU)
- Analysts: None.
- Total return with dividends: 1Y +1.4% vs S&P 500 +18.1%; 5Y +2.0% vs S&P 500 +85.1%.
Analysts (IRHOU)
Consensus None.
Total return (dividends reinvested) (IRHOU)
| 1Y (from 2025-12-17) | 5Y (from 2025-12-15) | |
|---|---|---|
| Total return | +1.4% | +2.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 4.3% | 4.2% |
| Max drawdown | -2.2% (Apr 2026→May 2026) | -2.1% (Apr 2026→Apr 2026) |
Key Statistics (as of October 16, 2026 at 05:49 UTC)
| Price | USD 10.14 |
|---|---|
| Change | ▼ 0.29% (down) |
| Previous Close | USD 10.17 |
| Open | USD 10.14 |
| Day Range | USD 10.14 – 10.14 |
| 52-Week Range | USD 9.94 – 11.29 |
| Volume | 100 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (IRHOU)
Nexqual's technical model rates IRHOU "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.6 (neutral) |
| vs SMA50 | Below (USD 10.18) |
| MACD | -0.01 (negative) |
Analyst Ratings (IRHOU)
Wall Street analysts rate IRHOU "None", per Nexqual as of October 16, 2026 at 05:49 UTC.
| Consensus Rating | None |
|---|
Financial Health Score (IRHOU)
Nexqual rates IRHOU's overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:49 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $2K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$962K (TTM) |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VYLR | Vylor Inc. | USD 73.34 | ▼ 4.68% |
| DMII | Drugs Made In America Acquisiti | USD 10.19 | ▲ 0% |
| CCXI | Churchill Capital Corp XI | USD 11.35 | ▲ 1.7% |
| EVAC | EQV Ventures Acquisition Corp. | USD 10.3 | ▼ 0.1% |
| BCSS | Bain Capital GSS Investment Cor | USD 10.22 | ▼ 0.15% |
| CEPF | Cantor Equity Partners IV, Inc. | USD 10.26 | ▼ 0.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt